Literature DB >> 35584701

Circular RNAs: Characterization, cellular roles, and applications.

Chu-Xiao Liu1, Ling-Ling Chen2.   

Abstract

Most circular RNAs are produced from the back-splicing of exons of precursor mRNAs. Recent technological advances have in part overcome problems with their circular conformation and sequence overlap with linear cognate mRNAs, allowing a better understanding of their cellular roles. Depending on their localization and specific interactions with DNA, RNA, and proteins, circular RNAs can modulate transcription and splicing, regulate stability and translation of cytoplasmic mRNAs, interfere with signaling pathways, and serve as templates for translation in different biological and pathophysiological contexts. Emerging applications of RNA circles to interfere with cellular processes, modulate immune responses, and direct translation into proteins shed new light on biomedical research. In this review, we discuss approaches used in circular RNA studies and the current understanding of their regulatory roles and potential applications.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RBP; RNA circle; RNA-binding protein; aptamer; back-splicing; circRNA; circular RNA application; circular RNA modality; circular RNA therapeutics; circular RNA translation; immunogenicity

Mesh:

Substances:

Year:  2022        PMID: 35584701     DOI: 10.1016/j.cell.2022.04.021

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  10 in total

1.  Circular and Fusion RNAs in Medulloblastoma Development.

Authors:  Ani Azatyan; Peter G Zaphiropoulos
Journal:  Cancers (Basel)       Date:  2022-06-26       Impact factor: 6.575

2.  Hsa_circ_0099630 knockdown induces the proliferation and osteogenic differentiation and attenuates the apoptosis of porphyromonas gingivalis lipopolysaccharide-induced human periodontal ligament fibroblasts.

Authors:  Yaru Wei; Zhengjun Peng
Journal:  Ann Transl Med       Date:  2022-09

Review 3.  Current advances and future perspectives on the functional roles and clinical implications of circular RNAs in esophageal squamous cell carcinoma: more influential than expected.

Authors:  Chenxi Ju; Jing He; Chang Wang; Jinxiu Sheng; Jinlin Jia; Dan Du; Hongle Li; Mingxia Zhou; Fucheng He
Journal:  Biomark Res       Date:  2022-06-07

4.  The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis.

Authors:  Boqiang Liu; Yuanshi Tian; Jing He; Qiuxia Gu; Binghan Jin; Hao Shen; Weiqi Li; Liang Shi; Hong Yu; Ge Shan; Xiujun Cai
Journal:  J Transl Med       Date:  2022-09-04       Impact factor: 8.440

Review 5.  The Role of Non-Coding RNAs in Glioma.

Authors:  Anshika Goenka; Deanna Marie Tiek; Xiao Song; Rebeca Piatniczka Iglesia; Minghui Lu; Bo Hu; Shi-Yuan Cheng
Journal:  Biomedicines       Date:  2022-08-20

Review 6.  Multiple Roles of m6A RNA Modification in Translational Regulation in Cancer.

Authors:  Guillermo Fernandez Rodriguez; Bianca Cesaro; Alessandro Fatica
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

7.  Type 1 Diabetes Mellitus-Related circRNAs Regulate CD4+ T Cell Functions.

Authors:  Jianni Chen; Guanfei Jia; Xue Lv; Shufa Li
Journal:  Biomed Res Int       Date:  2022-08-24       Impact factor: 3.246

Review 8.  Circular RNAs regulate parental gene expression: A new direction for molecular oncology research.

Authors:  Haicun Wang; Xin Gao; Shaobo Yu; Weina Wang; Guanglin Liu; Xingming Jiang; Dongsheng Sun
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

9.  Self-restricted circular RNA circSOX2 suppressed the malignant progression in SOX2-amplified LUSC.

Authors:  Yingkuan Liang; Nan Wang; Yijian Zhang; Wei Jiang; Chen Fang; Yu Feng; Haitao Ma; Feng Jiang; Gaochao Dong
Journal:  Cell Death Dis       Date:  2022-10-15       Impact factor: 9.685

Review 10.  Mechanism underlying circRNA dysregulation in the TME of digestive system cancer.

Authors:  Zeyu Wu; Xiao Yu; Shuijun Zhang; Yuting He; Wenzhi Guo
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.